奥库通过激活Nrf2/HO-1信号通路来缓解慢性阻塞性肺病
1Department of International Medical Center, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China. docliuting530@163.com.
Cell biochemistry and biophysics
|July 5, 2024
概括
在慢性阻塞性肺病 (COPD) 模型中,来自Eucommia ulmoides的Aucubin有效降低了炎症,氧化应激和亡. 它通过激活Nrf2/HO-1信号通路来起作用,为COPD提供了潜在的治疗策略.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重要的全球健康问题,死亡率高.
- 奥库是来自Eucommia ulmoides的天然化合物,具有已知的抗氧化和抗炎性质.
- 在COPD模型中研究aucubin的治疗潜力对于开发新疗法至关重要.
研究的目的:
- 在小鼠和细胞模型中评估aucubin在减轻COPD病理特征方面的疗效.
- 阐明潜在的分子机制,特别是Nrf2/HO-1信号通路的作用.
主要方法:
- 通过长期暴露于香烟烟雾 (CS) 来建立COPD小鼠模型.
- 评估炎症标志物,氧化应激指标和肺组织组织学的变化.
- 在实验室验证使用暴露于香烟烟雾提取物 (CSE) 的小鼠肺上皮细胞 (MLE12).
- 分析Nrf2/HO-1通路激活和Nrf2抑制的影响.
主要成果:
- 欧库显著降低了支气管洗液中的炎症细胞数量和炎症因子 (TNF-α,IL-6,IL-8).
- 奥库改善了CS诱导的氧化应激,肺,纤维化和肺组织的亡.
- 阿库在体内和体外都激活了Nrf2/HO-1信号通路.
- 抑制Nrf2消除了aucubin的保护作用,证实了其作用机制.
结论:
- 阿库在缓解COPD症状和病理方面显示出显著的治疗潜力.
- 奥库的保护作用是通过激活Nrf2/HO-1信号通路来实现的.
- 阿库是开发新型COPD疗法的有前途的天然化合物.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194